Report Detail
Global Fludeoxyglucose (18F) Radionuclide Injection Market Insights, Forecast to 2025
- RnM2390942 |
- 06 June, 2019 |
- Global |
- 116 Pages |
- QYResearch |
- Other
Fludeoxyglucose (18F) radionuclide injection is radioactive substance used for diagnostic purpose with Positron Emission Tomography (PET).
Advancement in radiopharmaceutical technologies along with more improve hardware and software of PET imaging are the primary factors driving the growth of Fludeoxyglucose (18F) Radionuclide Injection market.
United States is expected to dominate the global Fludeoxyglucose (18F) Radionuclide Injection market due to high healthcare infrastructure.
ter United States, Fludeoxyglucose (18F) Radionuclide Injection market is then followed by Europe and Asia-Pacific. Europe market is expected to grow due to rise in the number of manufacturing companies of Fludeoxyglucose (18F) Radionuclide Injection. In Asia-Pacific, India and China are expected to be major market owing to increasing geriatric population and cancer incidences.
The global Fludeoxyglucose (18F) Radionuclide Injection market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Fludeoxyglucose (18F) Radionuclide Injection market based on company, product type, end user and key regions.
This report studies the global market size of Fludeoxyglucose (18F) Radionuclide Injection in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Fludeoxyglucose (18F) Radionuclide Injection in these regions.
This research report categorizes the global Fludeoxyglucose (18F) Radionuclide Injection market by top players/brands, region, type and end user. This report also studies the global Fludeoxyglucose (18F) Radionuclide Injection market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Zevacor Pharma
Queen's PET Imaging
Triad Isotopes
NCM USA Bronx
Spectron MRC
Petnet Solutions
Shertech Laboratories
Precision Nuclear
Market size by Product
Cancer
Coronary Artery Disease
Others
Market size by End User
Hospitals
Clinics
Diagnostics Center
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Fludeoxyglucose (18F) Radionuclide Injection market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Fludeoxyglucose (18F) Radionuclide Injection market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Fludeoxyglucose (18F) Radionuclide Injection companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Fludeoxyglucose (18F) Radionuclide Injection submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Fludeoxyglucose (18F) Radionuclide Injection are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (Kg). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Fludeoxyglucose (18F) Radionuclide Injection market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Fludeoxyglucose (18F) Radionuclide Injection Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Fludeoxyglucose (18F) Radionuclide Injection Market Size Growth Rate by Product
- 1.4.2 Cancer
- 1.4.3 Coronary Artery Disease
- 1.4.4 Others
- 1.5 Market by End User
- 1.5.1 Global Fludeoxyglucose (18F) Radionuclide Injection Market Size Growth Rate by End User
- 1.5.2 Hospitals
- 1.5.3 Clinics
- 1.5.4 Diagnostics Center
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Fludeoxyglucose (18F) Radionuclide Injection Market Size
- 2.1.1 Global Fludeoxyglucose (18F) Radionuclide Injection Revenue 2014-2025
- 2.1.2 Global Fludeoxyglucose (18F) Radionuclide Injection Sales 2014-2025
- 2.2 Fludeoxyglucose (18F) Radionuclide Injection Growth Rate by Regions
- 2.2.1 Global Fludeoxyglucose (18F) Radionuclide Injection Sales by Regions
- 2.2.2 Global Fludeoxyglucose (18F) Radionuclide Injection Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Fludeoxyglucose (18F) Radionuclide Injection Sales by Manufacturers
- 3.1.1 Fludeoxyglucose (18F) Radionuclide Injection Sales by Manufacturers
- 3.1.2 Fludeoxyglucose (18F) Radionuclide Injection Sales Market Share by Manufacturers
- 3.1.3 Global Fludeoxyglucose (18F) Radionuclide Injection Market Concentration Ratio (CR5 and HHI)
- 3.2 Fludeoxyglucose (18F) Radionuclide Injection Revenue by Manufacturers
- 3.2.1 Fludeoxyglucose (18F) Radionuclide Injection Revenue by Manufacturers (2014-2019)
- 3.2.2 Fludeoxyglucose (18F) Radionuclide Injection Revenue Share by Manufacturers (2014-2019)
- 3.3 Fludeoxyglucose (18F) Radionuclide Injection Price by Manufacturers
- 3.4 Fludeoxyglucose (18F) Radionuclide Injection Manufacturing Base Distribution, Product Types
- 3.4.1 Fludeoxyglucose (18F) Radionuclide Injection Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Fludeoxyglucose (18F) Radionuclide Injection Product Type
- 3.4.3 Date of International Manufacturers Enter into Fludeoxyglucose (18F) Radionuclide Injection Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Fludeoxyglucose (18F) Radionuclide Injection Sales by Product
- 4.2 Global Fludeoxyglucose (18F) Radionuclide Injection Revenue by Product
- 4.3 Fludeoxyglucose (18F) Radionuclide Injection Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Fludeoxyglucose (18F) Radionuclide Injection Breakdown Data by End User
6 North America
- 6.1 North America Fludeoxyglucose (18F) Radionuclide Injection by Countries
- 6.1.1 North America Fludeoxyglucose (18F) Radionuclide Injection Sales by Countries
- 6.1.2 North America Fludeoxyglucose (18F) Radionuclide Injection Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Fludeoxyglucose (18F) Radionuclide Injection by Product
- 6.3 North America Fludeoxyglucose (18F) Radionuclide Injection by End User
7 Europe
- 7.1 Europe Fludeoxyglucose (18F) Radionuclide Injection by Countries
- 7.1.1 Europe Fludeoxyglucose (18F) Radionuclide Injection Sales by Countries
- 7.1.2 Europe Fludeoxyglucose (18F) Radionuclide Injection Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Fludeoxyglucose (18F) Radionuclide Injection by Product
- 7.3 Europe Fludeoxyglucose (18F) Radionuclide Injection by End User
8 Asia Pacific
- 8.1 Asia Pacific Fludeoxyglucose (18F) Radionuclide Injection by Countries
- 8.1.1 Asia Pacific Fludeoxyglucose (18F) Radionuclide Injection Sales by Countries
- 8.1.2 Asia Pacific Fludeoxyglucose (18F) Radionuclide Injection Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Fludeoxyglucose (18F) Radionuclide Injection by Product
- 8.3 Asia Pacific Fludeoxyglucose (18F) Radionuclide Injection by End User
9 Central & South America
- 9.1 Central & South America Fludeoxyglucose (18F) Radionuclide Injection by Countries
- 9.1.1 Central & South America Fludeoxyglucose (18F) Radionuclide Injection Sales by Countries
- 9.1.2 Central & South America Fludeoxyglucose (18F) Radionuclide Injection Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Fludeoxyglucose (18F) Radionuclide Injection by Product
- 9.3 Central & South America Fludeoxyglucose (18F) Radionuclide Injection by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Fludeoxyglucose (18F) Radionuclide Injection by Countries
- 10.1.1 Middle East and Africa Fludeoxyglucose (18F) Radionuclide Injection Sales by Countries
- 10.1.2 Middle East and Africa Fludeoxyglucose (18F) Radionuclide Injection Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Fludeoxyglucose (18F) Radionuclide Injection by Product
- 10.3 Middle East and Africa Fludeoxyglucose (18F) Radionuclide Injection by End User
11 Company Profiles
- 11.1 Zevacor Pharma
- 11.1.1 Zevacor Pharma Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Zevacor Pharma Fludeoxyglucose (18F) Radionuclide Injection Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Zevacor Pharma Fludeoxyglucose (18F) Radionuclide Injection Products Offered
- 11.1.5 Zevacor Pharma Recent Development
- 11.2 Queen's PET Imaging
- 11.2.1 Queen's PET Imaging Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Queen's PET Imaging Fludeoxyglucose (18F) Radionuclide Injection Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Queen's PET Imaging Fludeoxyglucose (18F) Radionuclide Injection Products Offered
- 11.2.5 Queen's PET Imaging Recent Development
- 11.3 Triad Isotopes
- 11.3.1 Triad Isotopes Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Triad Isotopes Fludeoxyglucose (18F) Radionuclide Injection Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Triad Isotopes Fludeoxyglucose (18F) Radionuclide Injection Products Offered
- 11.3.5 Triad Isotopes Recent Development
- 11.4 NCM USA Bronx
- 11.4.1 NCM USA Bronx Company Details
- 11.4.2 Company Business Overview
- 11.4.3 NCM USA Bronx Fludeoxyglucose (18F) Radionuclide Injection Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 NCM USA Bronx Fludeoxyglucose (18F) Radionuclide Injection Products Offered
- 11.4.5 NCM USA Bronx Recent Development
- 11.5 Spectron MRC
- 11.5.1 Spectron MRC Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Spectron MRC Fludeoxyglucose (18F) Radionuclide Injection Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Spectron MRC Fludeoxyglucose (18F) Radionuclide Injection Products Offered
- 11.5.5 Spectron MRC Recent Development
- 11.6 Petnet Solutions
- 11.6.1 Petnet Solutions Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Petnet Solutions Fludeoxyglucose (18F) Radionuclide Injection Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Petnet Solutions Fludeoxyglucose (18F) Radionuclide Injection Products Offered
- 11.6.5 Petnet Solutions Recent Development
- 11.7 Shertech Laboratories
- 11.7.1 Shertech Laboratories Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Shertech Laboratories Fludeoxyglucose (18F) Radionuclide Injection Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Shertech Laboratories Fludeoxyglucose (18F) Radionuclide Injection Products Offered
- 11.7.5 Shertech Laboratories Recent Development
- 11.8 Precision Nuclear
- 11.8.1 Precision Nuclear Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Precision Nuclear Fludeoxyglucose (18F) Radionuclide Injection Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Precision Nuclear Fludeoxyglucose (18F) Radionuclide Injection Products Offered
- 11.8.5 Precision Nuclear Recent Development
12 Future Forecast
- 12.1 Fludeoxyglucose (18F) Radionuclide Injection Market Forecast by Regions
- 12.1.1 Global Fludeoxyglucose (18F) Radionuclide Injection Sales Forecast by Regions 2019-2025
- 12.1.2 Global Fludeoxyglucose (18F) Radionuclide Injection Revenue Forecast by Regions 2019-2025
- 12.2 Fludeoxyglucose (18F) Radionuclide Injection Market Forecast by Product
- 12.2.1 Global Fludeoxyglucose (18F) Radionuclide Injection Sales Forecast by Product 2019-2025
- 12.2.2 Global Fludeoxyglucose (18F) Radionuclide Injection Revenue Forecast by Product 2019-2025
- 12.3 Fludeoxyglucose (18F) Radionuclide Injection Market Forecast by End User
- 12.4 North America Fludeoxyglucose (18F) Radionuclide Injection Forecast
- 12.5 Europe Fludeoxyglucose (18F) Radionuclide Injection Forecast
- 12.6 Asia Pacific Fludeoxyglucose (18F) Radionuclide Injection Forecast
- 12.7 Central & South America Fludeoxyglucose (18F) Radionuclide Injection Forecast
- 12.8 Middle East and Africa Fludeoxyglucose (18F) Radionuclide Injection Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Fludeoxyglucose (18F) Radionuclide Injection Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Fludeoxyglucose (18F) Radionuclide Injection. Industry analysis & Market Report on Fludeoxyglucose (18F) Radionuclide Injection is a syndicated market report, published as Global Fludeoxyglucose (18F) Radionuclide Injection Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Fludeoxyglucose (18F) Radionuclide Injection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
